Skip to main content
      EULAR 2024 Highlights: Saturday’s Recap with RheumNow https://t.co/BlOsbr9lYB

      Dr. John Cush RheumNow

      10 months ago
      EULAR 2024 Highlights: Saturday’s Recap with RheumNow https://t.co/BlOsbr9lYB
      #EULARBEST
      RCT of #upadacitinib in #GCA

      It works to steroid spare
      15 mg > 7.5 mg in outcomes
      Both >>placebo

      Janet Pope Janetbirdope

      10 months ago
      #EULARBEST RCT of #upadacitinib in #GCA It works to steroid spare 15 mg > 7.5 mg in outcomes Both >>placebo Ethically PBO had slower #prednisone taper Similar to #TCZ data What to choose in GCA IL6i IL17i JAKi @eular_org @RheumNow LBA0001 https://t.co/gy0TEiHxjo
      Does B Cell Depletion Matter?

      Dr. Yuz Yusof interviews Dr. Ed Vital regarding abstract OP0077 at Eular 2024 in Vienna,

      Dr. John Cush RheumNow

      10 months ago
      Does B Cell Depletion Matter? Dr. Yuz Yusof interviews Dr. Ed Vital regarding abstract OP0077 at Eular 2024 in Vienna, Austria. https://t.co/IjxGWWjoGD https://t.co/GwLjB4Z7ub
      Telespa - telemonitoring in AxSpA « minimal impact on disease control « never examine a patient again , never find a

      Peter Nash drpnash

      10 months ago
      Telespa - telemonitoring in AxSpA « minimal impact on disease control « never examine a patient again , never find any pathology outside of joints, remote SpAologists, no longer physicians - easy to train rheumatology nurses to do our jobs @RheumNow #EULAR2025
      #Scleroderma #recommendations
      #Rayanud’s
      #vasculopathy
      #digital #ulcers

      CCB
      PDE5i
      IV iloprost

      Bosentan for Digital

      Janet Pope Janetbirdope

      10 months ago
      #Scleroderma #recommendations #Rayanud’s #vasculopathy #digital #ulcers CCB PDE5i IV iloprost Bosentan for Digital ulcer prevention <not approved in NA> #EULAR2024 @EUSTAR_org @RheumNow #SSc https://t.co/9c2cHAptIC
      SHR032 chinese JAK1 inhib AS and PsA - typical efficacy and safety - looks like smells like tastes like JAK1 inhib but n

      Peter Nash drpnash

      10 months ago
      SHR032 chinese JAK1 inhib AS and PsA - typical efficacy and safety - looks like smells like tastes like JAK1 inhib but no zoster listed or acne, or anaemia with higher dose, 1 mace 1 vte @RheumNow #EULAR2024
      Duo IL17A,F #SONELOKIMAB
      RCT in active #PsA
      ACR50 around 46%

      Nanobody

      to me it looks like #Bimekizumab results
      So far

      Janet Pope Janetbirdope

      10 months ago
      Duo IL17A,F #SONELOKIMAB RCT in active #PsA ACR50 around 46% Nanobody to me it looks like #Bimekizumab results So far low #fungal infections OP0195 We are over run with + IL17i RCTs in #psoriatic #arthritis Impt~market /access/risk/benefit? #EULAR2024 @eular_org @RheumNow
      Ixokibep a small IL17Ai works in #PsA
      16 wks ▶️50% had PASI 100

      Fast
      40-42% ACR50
      Same rate of MDA
      Helped enthes

      Janet Pope Janetbirdope

      10 months ago
      Ixokibep a small IL17Ai works in #PsA 16 wks ▶️50% had PASI 100 Fast 40-42% ACR50 Same rate of MDA Helped enthesitis also ⬆️injection site rx’n Wow! But where to use vs 2 other IL17Ai and IL17AEi LB0005 #EULAR24 @eular_org @RheumNow
      The electronic nose, knows?

      Exhaled breath volatile organic compounds do surprisingly well in diagnosing RA. Really…

      David Liew drdavidliew

      10 months ago
      The electronic nose, knows? Exhaled breath volatile organic compounds do surprisingly well in diagnosing RA. Really… takes your breath away (as seen in @rheuma_doktorin’s highlights) #EULAR2024 POS0652 @RheumNow https://t.co/OCRHdZZS3Q
      Periodontal disease is a major factor in the development of RA - and that’s the tooth!

      in ACPA+ clinically suspect ar

      David Liew drdavidliew

      10 months ago
      Periodontal disease is a major factor in the development of RA - and that’s the tooth! in ACPA+ clinically suspect arthralgias, tooth extraction: adjusted HR 3.10 Population-level dental care? (as seen in @rheuma_doktorin’s highlights) #EULAR2024 POS0467 @RheumNow https://t.co/wN8bvBtv40
      The MRI SIJ findings in postpartum patients with buttock/pelvic pain remain stable in a 7 year follow up study. They ra

      Dr. Antoni Chan synovialjoints

      10 months ago
      The MRI SIJ findings in postpartum patients with buttock/pelvic pain remain stable in a 7 year follow up study. They rarely develop classical MRI features of axial SpA (i.e. erosion, fat > 1 cm in depth, backfill and ankylosis) or are diagnosed as axial SpA within an 8-year… https://t.co/8M0FP65KPS https://t.co/k1ruzjC7Zy
      Four phenotypes of chronic back pain suspicious of axial spondyloarthritis (axSpA) in the SPACE cohort. These groups wer

      Dr. Antoni Chan synovialjoints

      10 months ago
      Four phenotypes of chronic back pain suspicious of axial spondyloarthritis (axSpA) in the SPACE cohort. These groups were: They were “axial”, “axSpA with peripheral signs”, “at risk” and “no SpA”. Over a 2 year follow up, Transitions between the four classes over two years were… https://t.co/lF1wtAo46Q https://t.co/BXj1nw0tto
      PMR patients get too much steroid.

      Data across 27 million people in England, n=39,438 with PMR.
      The blue are getting mo

      David Liew drdavidliew

      10 months ago
      PMR patients get too much steroid. Data across 27 million people in England, n=39,438 with PMR. The blue are getting more pred than guidelines. Like everything in rheum: we need to be giving less pred, not more. Lumping PMR in with GCA won’t help. #EULAR2024 POS0411 @RheumNow https://t.co/bsi3lrAafm
      ×